NuVasive Inventory Turnover Ratio 2006-2019 | NUVA
NuVasive inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| NuVasive Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.945B | $1.102B |
| NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $146.709B | 28.48 |
| Medtronic (MDT) | Ireland | $133.941B | 19.13 |
| Stryker (SYK) | United States | $76.636B | 27.35 |
| Boston Scientific (BSX) | United States | $58.213B | 27.91 |
| Baxter (BAX) | United States | $41.870B | 26.39 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.961B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.488B | 40.69 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.277B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.004B | 16.06 |
| Terumo (TRUMY) | Japan | $22.862B | 26.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.073B | 0.00 |
| ResMed (RMD) | United States | $17.690B | 33.80 |
| Canopy Growth (CGC) | Canada | $12.296B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.175B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.220B | 48.88 |
| William Demant Holdings (WILYY) | Denmark | $7.651B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $7.261B | 71.60 |
| Insulet (PODD) | United States | $7.142B | 520.35 |
| Hill-Rom Holdings (HRC) | United States | $7.099B | 21.52 |
| Perrigo (PRGO) | Ireland | $6.850B | 11.58 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.283B | 51.28 |
| ICU Medical (ICUI) | United States | $5.126B | 30.59 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.014B | 0.00 |
| Neogen (NEOG) | United States | $3.340B | 54.31 |
| Hutchison China MediTech (HCM) | China | $2.954B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.762B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.459B | 52.40 |
| Quidel (QDEL) | United States | $2.264B | 23.50 |
| Aphria (APHA) | $1.581B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.532B | 879.80 |
| Phibro Animal Health (PAHC) | United States | $1.229B | 18.42 |
| AtriCure (ATRC) | United States | $1.186B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.172B | 24.87 |
| Lantheus Holdings (LNTH) | United States | $1.081B | 28.70 |
| NanoString Technologies (NSTG) | United States | $1.069B | 0.00 |
| PetIQ (PETQ) | United States | $1.001B | 24.32 |
| Quanterix (QTRX) | United States | $0.773B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.758B | 21.26 |
| Cerus (CERS) | United States | $0.757B | 0.00 |
| Omeros (OMER) | United States | $0.747B | 0.00 |
| MacroGenics (MGNX) | United States | $0.742B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.693B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.583B | 28.24 |
| Surmodics (SRDX) | United States | $0.531B | 77.12 |
| OraSure Technologies (OSUR) | United States | $0.527B | 24.26 |
| Meridian Bioscience (VIVO) | United States | $0.487B | 14.90 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.393B | 0.00 |
| Vapotherm (VAPO) | United States | $0.337B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.325B | 22.53 |
| BioLife Solutions (BLFS) | United States | $0.311B | 97.35 |
| Zynex (ZYXI) | United States | $0.239B | 24.53 |
| Cytosorbents (CTSO) | United States | $0.232B | 0.00 |
| Bovie Medical (APYX) | United States | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.192B | 4.07 |
| Chimerix (CMRX) | United States | $0.188B | 0.00 |
| United Health Products (UEEC) | United States | $0.174B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.173B | 0.00 |
| Female Health (VERU) | United States | $0.147B | 0.00 |
| Fonar (FONR) | United States | $0.137B | 7.22 |
| Chembio Diagnostics (CEMI) | United States | $0.101B | 0.00 |
| United-Guardian (UG) | United States | $0.094B | 20.60 |
| InfuSystems Holdings (INFU) | United States | $0.092B | 0.00 |
| Surface Oncology (SURF) | United States | $0.074B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.062B | 21.58 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.062B | 0.00 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
